Shannon M. Mumenthaler Lawrence J. Ellison Institute for Transformative Medicine University of Southern California (USC) Biography Publications Institution JoVE Articles Shannon M. Mumenthaler has not added a biography. If you are Shannon M. Mumenthaler and would like to personalize this page please email our Author Liaison for assistance. Publications Progress Towards Computational 3-D Multicellular Systems Biology Advances in Experimental Medicine and Biology. 2016 | Pubmed ID: 27739051 Single Cell Dynamic Phenotyping Scientific Reports. Oct, 2016 | Pubmed ID: 27708391 Quantifying Differences in Cell Line Population Dynamics Using CellPD BMC Systems Biology. Sep, 2016 | Pubmed ID: 27655224 Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors PLoS Computational Biology. Aug, 2016 | Pubmed ID: 27560187 Dual Transcript and Protein Quantification in a Massive Single Cell Array Lab on a Chip. Oct, 2016 | Pubmed ID: 27546183 A High-content Image-based Method for Quantitatively Studying Context-dependent Cell Population Dynamics Scientific Reports. Jul, 2016 | Pubmed ID: 27452732 Significance of Duon Mutations in Cancer Genomes Scientific Reports. Jun, 2016 | Pubmed ID: 27272679 Phosphorylated Ribosomal S6 (p-rpS6) As a Post-treatment Indicator of HER2 Signalling Targeted Drug Resistance Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 2015 | Pubmed ID: 26329528 The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells Cancer Informatics. 2015 | Pubmed ID: 26244007 Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma PloS One. 2015 | Pubmed ID: 26061425 Anti-MET ImmunoPET for Non-small Cell Lung Cancer Using Novel Fully Human Antibody Fragments Molecular Cancer Therapeutics. Nov, 2014 | Pubmed ID: 25143449 The Need for Integrative Computational Oncology: An Illustrated Example Through MMP-Mediated Tissue Degradation Frontiers in Oncology. 2013 | Pubmed ID: 23898463 A Physical Sciences Network Characterization of Non-tumorigenic and Metastatic Cells Scientific Reports. 2013 | Pubmed ID: 23618955 Cancer As a Moving Target: Understanding the Composition and Rebound Growth Kinetics of Recurrent Tumors Evolutionary Applications. Jan, 2013 | Pubmed ID: 23396647 Evolutionary Modeling of Combination Treatment Strategies to Overcome Resistance to Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Molecular Pharmaceutics. Dec, 2011 | Pubmed ID: 21995722 Pharmacologic Inhibition of Pim Kinases Alters Prostate Cancer Cell Growth and Resensitizes Chemoresistant Cells to Taxanes Molecular Cancer Therapeutics. Oct, 2009 | Pubmed ID: 19825806 CD4+ NK Cells Can Be Productively Infected with HIV, Leading to Downregulation of CD4 Expression and Changes in Function Virology. Apr, 2009 | Pubmed ID: 19251297 Disruption of Arginase II Alters Prostate Tumor Formation in TRAMP Mice The Prostate. Oct, 2008 | Pubmed ID: 18663728 Expression of Arginase II in Prostate Cancer International Journal of Oncology. Feb, 2008 | Pubmed ID: 18202758 Дискриминация и характеристика гетеросекулярных групп населения с использованием методов количественной визуализации Colleen M. Garvey1, Torin A. Gerhart1, Shannon M. Mumenthaler1 1Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California (USC) JoVE 55844 Biology
Дискриминация и характеристика гетеросекулярных групп населения с использованием методов количественной визуализации Colleen M. Garvey1, Torin A. Gerhart1, Shannon M. Mumenthaler1 1Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California (USC) JoVE 55844 Biology